Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    63,846.82
    -690.32 (-1.07%)
     

  • CMC Crypto 200

    1,328.24
    -68.30 (-4.89%)
     

  • S&P 500

    5,110.78
    +62.36 (+1.24%)
     

  • Dow

    38,301.20
    +215.40 (+0.57%)
     

  • Nasdaq

    15,964.82
    +353.06 (+2.26%)
     

  • Gold

    2,348.30
    +5.80 (+0.25%)
     

  • Crude Oil

    83.80
    +0.23 (+0.28%)
     

  • 10-Yr Bond

    4.6750
    -0.0310 (-0.66%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Novo Nordisk's diabetes pill Rybelsus to be covered by Express Scripts

Reuters
The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the facade of a production plant in Chartres

COPENHAGEN (Reuters) - Novo Nordisk's <NOVOb.CO> new diabetes pill, Rybelsus, will be covered by Express Scripts Holding Co, one of the largest U.S. pharmacy benefit managers, the Danish drugmaker said on Friday.

Pharmacy benefit managers act as middlemen in the drug supply chain, and negotiate discounts on drugs on behalf of health insurers.

Depending on the discounts drugmakers are willing to provide, pharmacy benefits managers make decisions about which drugs to include in coverage plans.

Novo Nordisk declined to comment on what discounts it had offered.

The news, first reported by Danish daily Børsen on Friday, was confirmed to Reuters by a Novo Nordisk spokesman.

(Reporting by Stine Jacobsen; editing by Muralikumar Anantharaman and Jason Neely)